PatientsVille.com Logo

DRUG WITHDRAWAL SYNDROME and Levitra

PatientsVille

DRUG WITHDRAWAL SYNDROME Symptoms and Causes

When you are pregnant, you are not just "eating for two." You also breathe and drink for two. If you smoke, use alcohol or take illegal drugs, so does your unborn baby.

To protect your baby, you should avoid

  • Tobacco.Smoking during pregnancy passes nicotine, carbon monoxide, and other harmful chemicals to your baby. This could cause many problems for your unborn baby's development. It raises the risk of your baby being born too small, too early, or with birth defects. Smoking can also affect babies after they are born. Your baby would be more likely to develop diseases such as asthma and obesity. There is also a higher risk of dying from sudden infant death syndrome (SIDS).
  • Drinking alcohol. There is no known amount of alcohol that is safe for a woman to drink during pregnancy. If you drink alcohol when you are pregnant, your child could be born with lifelong fetal alcohol syndrome disorders (FASD). Children with FASD can have a mix of physical, behavioral, and learning problems.
  • Illegal drugs. Using illegal drugs such as cocaine and methamphetamines may cause underweight babies, birth defects, or withdrawal symptoms after birth.
  • Misusing prescription drugs. If you are taking prescription medicines, carefully follow your health care provider's instructions. It can be dangerous to take more medicines than you are supposed to, use them to get high, or take someone else's medicines. For example, misusing opioids can cause birth defects, withdrawal in the baby, or even loss of the baby.

If you are pregnant and you are doing any of these things, get help. Your healthcare provider can recommend programs to help you quit. You and your baby's health depend on it.

Dept. of Health and Human Services Office on Women's Health

Check out the latest treatments for DRUG WITHDRAWAL SYNDROME

DRUG WITHDRAWAL SYNDROME treatment research studies

Levitra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Levitra Side Effects

Erectile Dysfunction (899)
Headache (338)
Flushing (154)
Dizziness (121)
Nasal Congestion (104)
Vision Blurred (101)
Erection Increased (87)
Adverse Event (67)
Visual Disturbance (60)
Nausea (60)
Visual Acuity Reduced (51)
Chest Pain (47)
Feeling Abnormal (45)
Optic Ischaemic Neuropathy (44)
Dyspnoea (40)
Deafness Unilateral (38)
Visual Field Defect (36)
Dyspepsia (35)
Loss Of Consciousness (35)
Tinnitus (33)
Eye Pain (33)
Eye Disorder (33)
Cerebrovascular Accident (33)
Diarrhoea (30)
Heart Rate Increased (30)
Hypotension (29)
Blood Pressure Decreased (29)
Photopsia (27)
Feeling Hot (26)
Myocardial Infarction (26)
Vomiting (25)
Penile Pain (25)
Fatigue (24)
Ejaculation Failure (24)
Back Pain (23)
Asthenia (23)
Hypertension (23)
Visual Impairment (22)
Rhinorrhoea (22)
Ocular Hyperaemia (22)
Chest Discomfort (21)
Palpitations (21)
Penis Disorder (21)
Photophobia (21)
Ejaculation Disorder (20)
Chills (20)
Erythema (20)
No Adverse Event (20)
Transient Ischaemic Attack (20)
Fall (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

DRUG WITHDRAWAL SYNDROME Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i
Condition: Impotence
Interventions: Drug: Sildenafil, Vardenafil;   Drug: Sildenafil;   Drug: Vardenafil;   Drug: Sildenafil & Vardenafil
Outcome Measure: increase of 5 points or more in the IIEF erectile function domain
2 Unknown  A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
Condition: Erectile Dysfunction
Interventions: Drug: Vardenafil;   Drug: Placebo
Outcome Measures: EF domain score of IIEF;   IIEF/SEP/GAQ
3 Not yet recruiting Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Levitra
Outcome Measures: Change in 6 minute walk or New York Heart Association functional class.;   Changes in Pulmonary artery pressure assessed (by echo), exercise test parameters, pro-NT BNP, quality of life. Clinical worsening during study, study drop-out and adverse events during the study.
4 Recruiting Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Conditions: Type 2 Diabetes;   Hypogonadism
Intervention: Drug: Testosterone
Outcome Measures: Improvement in endothelial dependent and endothelial-independent vasodilatation;   Markers of endothelial function
5 Unknown  Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Tadalafil;   Drug: Vardenafil
Outcome Measures: Six minute walking distance;   Level of pro-NT BNP;   Echo-derived parameters;   Cardiopulmonary exercise test
6 Recruiting PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Condition: Anterior Ischemic Optic Neuropathy
Intervention: Drug: Diagnostic procedures
Outcome Measures: Confirmed diagnosis of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION);   Any additional safety information provided by the subject
7 Unknown  Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
Conditions: Erectile Dysfunction;   Hypogonadotrophic Males
Intervention: Drug: Testosterone Undecanoate and/or PDE-5
Outcome Measures: Score higher than or equal to 21 of the erectile dysfunction domain of the IIEF, or response to treatment;   and/or an affirmative response to the GAQ will be considered for the analysis
8 Recruiting A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
Condition: Monoclonal B-Cell Lymphocytosis
Intervention:
Outcome Measures: To estimate the cell proilferation rate of tumor cells in individuals with MBL, CLL/SLL, and MCL.;   Proliferation rate in tissue compared to blood, disappearance rate of labeled cells from the blood and tissue and the safety profile of heavy water in the study population/
9 Unknown  Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Conditions: Impotence;   Prostatic Neoplasms
Interventions: Drug: Sildenafil therapy plus post-NSRRP HBO2T;   Drug: Sildenafil therapy plus sham post-NSRRP HBO2T
Outcome Measures: Erectile function domain of Internation Index of Erectile Function (IIEF);   clinical or biochemical recurrence of cancer